SILK RD MED INC's ticker is SILK and the CUSIP is 82710M100. A total of 168 filers reported holding SILK RD MED INC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139,332 | -40.8% | 9,295 | +28.3% | 0.00% | 0.0% |
| Q2 2023 | $235,423 | -4.3% | 7,246 | +15.2% | 0.00% | 0.0% |
| Q1 2023 | $246,089 | -12.7% | 6,289 | +18.0% | 0.00% | -50.0% |
| Q4 2022 | $281,743 | +40.9% | 5,331 | +20.2% | 0.00% | +100.0% |
| Q3 2022 | $200,000 | +24.2% | 4,434 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $161,000 | -12.0% | 4,434 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $183,000 | -33.7% | 4,434 | -31.7% | 0.00% | 0.0% |
| Q4 2021 | $276,000 | +49.2% | 6,488 | +92.9% | 0.00% | 0.0% |
| Q3 2021 | $185,000 | +14.9% | 3,363 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $161,000 | -5.3% | 3,363 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $170,000 | -19.8% | 3,363 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $212,000 | -6.2% | 3,363 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $226,000 | +60.3% | 3,363 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $141,000 | +76.2% | 3,363 | +32.6% | 0.00% | 0.0% |
| Q1 2020 | $80,000 | +95.1% | 2,537 | +147.0% | 0.00% | – |
| Q4 2019 | $41,000 | – | 1,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTORAL ASSET MANAGEMENT INC | 399,483 | $25,159,000 | 1.77% |
| NEXT CENTURY GROWTH INVESTORS LLC | 313,534 | $19,746,000 | 1.66% |
| Graticule Asia Macro Advisors LLC | 52,565 | $3,311,000 | 1.59% |
| Bullseye Asset Management LLC | 58,112 | $3,659,000 | 1.36% |
| EMC Capital Management | 24,598 | $1,549,000 | 1.18% |
| Parkman Healthcare Partners LLC | 67,854 | $4,273,000 | 1.10% |
| Nicholas Investment Partners, LP | 219,483 | $13,823,000 | 1.07% |
| SCHOLTZ & COMPANY, LLC | 37,517 | $2,363,000 | 0.92% |
| WASATCH ADVISORS LP | 2,630,013 | $165,638,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 125,000 | $7,873,000 | 0.64% |